Corydaline-impurities | Pharmaffiliates

Corydaline

Corydaline is currently in clinical trials as a potential treatment for functional dyspepsia. It is an acetylcholinesterase inhibitor.Reference standards of Corydaline API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Corydaline - API Standards 
    [catalogue_number] => PA 82 18000
    [category_ids] => ,78,70,82,
    [chemical_name] => 
    [weight] => 369.46
    [form] => C22H27NO4
    [cas] => 518-69-4
    [pslug] => 518-69-4-corydaline-api-pa8218000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 82 18000

Corydaline - API Standards


  • Catalogue No.:PA 82 18000

  • CAS :

    518-69-4

  • Molecular Formula : C22H27NO4

  • Molecular Weight : 369.46